06877.HK
Top Eminent Healthcare Group Limited
HKSE · Financial Services · Financial - Capital Markets · HK
HKD 0.10
−1.00%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 177.3M | 109.8M | 86.5M | 191.2M | 39.1M |
| Cost of Revenue | 82.9M | 66.3M | 58.2M | 156.6M | 34.8M |
| Gross Profit | 127.6M | 40.6M | 28.3M | 34.6M | 4.4M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 41.3M | 35.4M | 22.1M | 22.8M | 11.5M |
| General & Admin Expense | 15.9M | 15.8M | 9.7M | 12.9M | 7.3M |
| Selling & Marketing Expense | 25.4M | 19.6M | 12.4M | 9.9M | 4.1M |
| Other Expenses | 33.8M | 11.8M | 9.0M | (2.8M) | 3.7M |
| Total Operating Expenses | 75.1M | 47.3M | 31.1M | 20.0M | 15.2M |
| Cost and Expenses | 94.4M | 113.5M | 89.3M | 176.6M | 49.9M |
| Operating Income (EBIT) | (11.1M) | (6.5M) | (2.9M) | 14.6M | (10.8M) |
| Non-Operating | |||||
| Interest Income | 7.6M | 7.6M | 9.3M | 7.8M | 1.3M |
| Interest Expense | 86.0K | — | 268.0K | — | 135.0K |
| Net Interest Income | 7.5M | 7.6M | 9.0M | 7.8M | 1.2M |
| Other Non-Op Income/Expense | 9.1M | (110.0K) | 15.4M | 291.0K | (135.0K) |
| Non-Operating Income (excl Interest) | 80.8M | — | (202.0K) | 8.1M | 1.5M |
| EBT (Pre-Tax Income) | (2.0M) | (6.7M) | 12.6M | 14.6M | (10.9M) |
| Income Tax Expense | 588.0K | 454.0K | 1.3M | 1.7M | 97.0K |
| Bottom Line | |||||
| Net Income | (5.3M) | (7.1M) | 11.3M | 9.8M | (31.1M) |
| Earnings from Cont. Ops | (5.3M) | (7.1M) | 11.3M | 12.8M | (11.0M) |
| Earnings from Discont. Ops | — | — | — | (3.0M) | (20.0M) |
| Bottom Line Net Income | (2.8M) | (7.1M) | 11.3M | 9.8M | (31.1M) |
| Per Share | |||||
| Basic EPS | (HK$0.00) | (HK$0.00) | HK$0.01 | HK$0.00 | (HK$0.02) |
| Diluted EPS | (HK$0.00) | (HK$0.00) | HK$0.01 | HK$0.00 | (HK$0.02) |
| Revenue Per Share | HK$0.09 | HK$0.05 | HK$0.04 | HK$0.09 | HK$0.02 |
| Shares | |||||
| Basic Shares Outstanding | 2.0B | 2.0B | 2.0B | 2.0B | 2.0B |
| Diluted Shares Outstanding | 2.0B | 2.0B | 2.0B | 2.0B | 2.0B |
| Profitability Metrics | |||||
| EBITDA | (2.9M) | (6.5M) | (2.5M) | 7.0M | (8.2M) |
| D&A | 22.0K | 51.0K | 310.0K | 456.0K | 2.6M |
| EBIT | (3.0M) | (6.5M) | (2.9M) | 6.5M | (10.8M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026